From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy.

Front Cardiovasc Med · 2025 · PMC12498300 · PMID 41059442

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Rates of early cardiotoxicity (metoprolol: 10%, enalapril: 12%, control: 15%, P = 0.12) and late cardiotoxicity (5%, 6%, and 8%, respectively, P = 0.18) did not reach statistical significance ( 36 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.